Nanovaccine Displaying Immunodominant T Cell Epitopes of Fibroblast Activation Protein Is Effective Against Desmoplastic Tumors

Investigators reported a cancer nanovaccine targeting fibroblast activation protein α-expressing cancer-associated fibroblasts as a potential pan-tumor vaccine.